RxDoctor Payments Data

Laxmaiah Manchikanti, MD

Interventional Pain Medicine · Paducah, KYNPI 1730178799

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 18 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by Medtronic at 38.0% of the total. Reporting peaked in 2023 at $349 and has fallen 78.7% since, to $74 in 2025. That places this record below the midpoint for interventional pain medicine clinicians in KY, where the typical reported total is $3,169.

$695in general payments, 2019–2025

Across 18 payments — averaging $38.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$264
  • Abbott$162
  • Stimwave Technologies Incorporated$109
  • Curonix LLC$98
  • Biotronik NRO, Inc.$32
  • Nevro Corp.$16
  • plus $14 from 1 others
$50in research payments, 2019–2025

Across 1 payment — averaging $50.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Boston Scientific$50

What the payments were for

  • Food & beverage$695100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$695 in reported general payments places this provider in the 15th percentile of 55 interventional pain medicine providers in Kentucky.

See all interventional pain medicine providers in Kentucky

Medicare billing

Part B allowed, 2024
$379,397
Medicare patients
710
Services billed
3,913

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen3,657$93,615
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen4,216$88,340
MovantikNaloxegol Oxalate119$47,620
Gabapentin2,586$22,507
OxycontinOxycodone Hcl27$19,793
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl129$19,281
NucyntaTapentadol Hcl20$18,949
Oxycodone Hcl701$13,493
Morphine Sulfate ErMorphine Sulfate393$12,593
LyricaPregabalin12$12,415
Pregabalin534$10,404
Naloxone Hcl141$8,369
Lidocaine99$6,711
Cyclobenzaprine Hcl675$5,253
Tizanidine Hcl798$5,251

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Paducah

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →